The “Genius” Plan: Penny Stock Insiders vs. Section 5 (Guess Who Wins)
Officers, directors, and other insiders try to “control” the flow of public sales - sometimes under the banner of Rule 144 -…
Read MoreReverse Merger to Go Public: Legal & Regulatory Risks
A reverse merger can be a viable path for a private company to gain a public listing, offering speed, cost efficiency, and…
Read MoreOTC Markets’ Role in Secondary Offerings and Resales
The critical role of OTC Markets in facilitating secondary offerings and resales of restricted and control securities under SEC Rule 144. This…
Read MoreReverse Mergers and OTC Markets: Compliance After the Transaction
This article discusses reverse mergers and the crucial need for post-merger compliance to ensure trading eligibility on OTC Markets. A reverse merger,…
Read MoreWhy So Few Brokerage Firms Accept OTC Markets Shares — And What It Means for Investors
For many retail investors, trading or depositing shares of OTC-traded companies is challenging. A significant number of brokerage firms impose restrictions—driven by…
Read MoreHigh Risk or Hidden Opportunity? Due Diligence When Investing in OTC IPOs and Pre-IPO Shares
This article provides a comprehensive guide to due diligence for investors interested in OTC IPOs and Pre-IPO Shares, emphasizing the high-risk nature…
Read MoreCorporate Actions and Symbol Changes on OTC Markets
The article explains how public companies quoted on OTC Markets must handle corporate actions—such as name or symbol changes, stock splits, mergers,…
Read MoreThe Penny Stock Graveyard – The OTC Markets Expert Market Explained: What Happens When Issuers Lose Quotation Eligibility
This article explains how issuers are downgraded to the OTC Markets Expert Market after losing quotation eligibility under SEC Rule 15c2-11, how…
Read MoreOTC Markets Liquidity and Price Discovery
This article from Hamilton & Associates Law Group explores liquidity and price discovery on the OTC Markets, highlighting their unique operations compared…
Read MoreOTC Markets Listing for Canadian Issuers
Canadian public companies can reach U.S. investors by dual listing on OTC Markets through the Multijurisdictional Disclosure System (MJDS). Eligible issuers may…
Read MoreCompliance for Cryptocurrency and Digital-Asset Issuers on OTC Markets
Crypto and blockchain issuers seeking OTC Markets quotation must comply with SEC Rule 15c2-11 by providing transparent disclosures on token operations, financials,…
Read MoreToxic Convertible Financing and OTC Markets Issuers
This article discusses the risks and consequences of toxic convertible financing, also known as "death spiral financing," for small and emerging companies…
Read MoreComparing OTCQX, OTCQB, and OTCID: Which Tier Is Right for Your Company?
This article from Hamilton & Associates Law Group compares the three main tiers of the OTC Markets Group—OTCQX, OTCQB, and OTCID (formerly…
Read MoreUplisting from OTC Markets to Nasdaq or NYSE: The Uplisting Path and Compliance Milestones
The ultimate guide to uplisting from OTC Markets to Nasdaq or NYSE. Learn the strategic path, compliance milestones, and 'Corporate Cleanup' necessary…
Read MoreCautionary Tales from the OTC Markets
The OTC Markets can serve as either a launchpad to major exchanges or a dead end, depending on issuer transparency, governance, and…
Read MoreCommon Disclosure Deficiencies Leading to OTC Markets Suspension
The document outlines common disclosure deficiencies that lead to OTC Markets suspending or downgrading issuers under Rule 15c2-11, which requires current, publicly…
Read MoreAnnual and Quarterly Reporting Under the OTC Markets Alternative Reporting Standard
The OTC Markets Alternative Reporting Standard outlines disclosure requirements for non-SEC-reporting issuers on OTCIQ, including annual and quarterly reports, officer certifications, and…
Read MoreSEC and FINRA Enforcement Trends in the OTC Market
The have intensified enforcement in the OTC Markets. The focus has shifted sharply toward broker-dealer gatekeeper obligations, fraudulent stock promotions, and manipulative…
Read MorePromotional Activity & Investor Relations Rules on OTC Markets
OTC Markets’ Stock Promotion Policy governs any public communication—press releases, newsletters, videos, email blasts, or social-media posts—that could influence trading activity or…
Read MoreOTC Markets Direct – Bypassing the Sponsoring Market Maker Under SEC Rule 15c2-11
Issuers may now work directly with OTC Markets through its OTCIQ Portal, bypassing the sponsoring market maker while maintaining full compliance under…
Read MoreThe Role of Transfer Agents in OTC Markets Compliance
In the OTC Markets ecosystem, transfer agents play a critical — yet often overlooked — role in ensuring compliance, shareholder transparency, and…
Read MoreUplisting from OTC Markets to Nasdaq or NYSE
Uplisting from the OTC Markets to Nasdaq or NYSE American represents a pivotal transition for emerging companies seeking greater liquidity, institutional visibility,…
Read MoreWhen Short Sellers Hit OTC Markets Stocks – Securities Lawyer 101
Short selling — the sale of borrowed shares with the expectation of repurchasing them later at a lower price — plays a…
Read MoreDirect Public Offerings in 2025
A Direct Public Offering (DPO) is an effective method for going public. Private companies may also raise capital by selling securities directly…
Read MoreSEC Dealer Rule Collapse: Impact on Toxic Lenders & OTC Penny Stocks
Learn how the SEC's Dealer Rule targeted toxic lenders in penny stock markets — and why its defeat means ongoing risks for…
Read More